Working collaboratively with patients, families, patient advocates, and healthcare professionals.
People living with calcification disorders need new treatment options. Inozyme Pharma is on a mission to find a breakthrough treatment.
We are committed to supporting the needs of patients, families, and healthcare professionals by providing disease education materials, resources for connecting with patient support groups, and updates on current development programs.
We provide a no-cost genetic testing program to improve detection and understanding of two rare calcification disorders, ENPP1 Deficiency and ABCC6 Deficiency. For more information about our genetic testing program and to see if you are eligible to participate, please click here.